Keyphrases
Glioblastoma Progression
100%
Cell Plasticity
100%
Glioblastoma
100%
RRM2
40%
Deoxyribonucleoside Triphosphates
30%
Temozolomide
30%
Chemoresistance
30%
3-AP
20%
Tumor Recurrence
20%
Radiochemotherapy
10%
Limited Accessibility
10%
Brain Permeability
10%
Conventional Radiotherapy
10%
Nanotherapeutics
10%
Novel Mechanism
10%
Mechanism of Action
10%
Regulatory Subunit
10%
Chemotherapy
10%
Biogenesis
10%
Blood-brain
10%
Patient-derived Xenograft
10%
Cell Growth
10%
Individual Cells
10%
Chemotherapy Resistance
10%
Stable Cell Line
10%
DNA Repair
10%
Expression Pattern
10%
Clinical Grade
10%
Conventional Chemotherapy
10%
Ribonucleotide Reductase
10%
Adaptation
10%
Distinct Subtypes
10%
Single-cell RNA Sequencing (scRNA-seq)
10%
DNA Replication
10%
Patient Samples
10%
Metabolic Adaptation
10%
Expression Activity
10%
Resistance to Therapy
10%
Biochemistry, Genetics and Molecular Biology
RRM2
100%
Cell Plasticity
100%
Drug Resistance
75%
Stable Cell
25%
DNA Repair
25%
Biogenesis
25%
RNA Sequence
25%
Cell Growth
25%
DNA Synthesis
25%
Ribonucleotide Reductase
25%
Medicine and Dentistry
Glioblastoma
100%
Cell Plasticity
100%
Temozolomide
27%
Drug Resistance
27%
Tumor Recurrence
18%
Xenograft
9%
RNA Sequence
9%
DNA Repair
9%
Biogenesis
9%
Cell Growth
9%
Recurrent Disease
9%
DNA Synthesis
9%
Ribonucleotide Reductase
9%
Radiation Therapy
9%